The abstract is read at the publisher; the summary is JClub's.
Engineered plasmid-free Escherichia coli strain H17 produced 142.15 g/L L-homoserine at 88 h in fed-batch fermentation, achieving 0.52 g/g glucose yield and 1.62 g/L/h productivity.
- Why it matters: High-titer L-homoserine production is needed for downstream uses like glufosinate-ammonium, but plasmid-free Escherichia coli strains require tight, scalable control of precursor supply and redox balance.
- What they did: The team built a leaky auxotrophic strain, increased thrA copy number, restored PTS for faster glucose uptake, and engineered carboxylation to boost oxaloacetate formation, then added a dual-function quorum sensing dynamic regulation circuit.
- The result: The combined metabolic engineering and dual-function QS regulation enabled one of the highest reported HOM titers in plasmid-free strains, supporting extension of the QS strategy to other metabolites.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.